FesariusTherapeutics receives NIH Commercial Readiness grant for DermiSphere™ dermal regeneration template in preparation for market release streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ FesariusTherapeutics, Inc., an emerging bioregenerative technology company focused on the development, manufacture and commercialization of.
Dr. Jason Spector, plastic and reconstructive surgery, and his lab at Weill Cornell Medicine published a study on March 8 that described a breast reconstruction technique utilizing a 3D-printed scaffold. The newly developed process aims to achieve softer, more natural and higher quality reconstructed nipples for breast cancer patients after mastectomies.